✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Ajanta Pharma Ltd.

AJANTPHARM

Market Cap
₹34,539 Cr.
P/E
38.47

Ajanta Pharma Ltd.

  • Ajanta Pharma
  • Ipca Laboratories
  • Glenmark Pharma
  • TJI Pharma
FAQs on Ajanta Pharma Ltd. Shareprice

Ajanta Pharma has given lower returns compared to its competitors.
Ajanta Pharma has grown at ~21.8% over the last 4yrs while peers have grown at a median rate of 23.42%

Yes, Ajanta Pharma is expensive.
Latest PE of Ajanta Pharma is 38.62, while 3 year average PE is 30.34.
Also latest EV/EBITDA of Ajanta Pharma is 27.9 while 3yr average is 22.03.

View FAQ's On Business
Growth Table
  • Ajanta Pharma Ltd.
  • Ipca Laboratories
  • Glenmark Pharma
Balance Sheet
  • Ajanta Pharma Ltd.
  • Ipca Laboratories
  • Glenmark Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Ajanta Pharma Ltd.
  • Ipca Laboratories
  • Glenmark Pharma
Cash Flow
  • Ajanta Pharma Ltd.
  • Ipca Laboratories
  • Glenmark Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Ajanta Pharma Ltd.
  • Ipca Laboratories
  • Glenmark Pharma
Quarterly Results
  • Ajanta Pharma Ltd.
  • Ipca Laboratories
  • Glenmark Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Ajanta Pharma Ltd. Financials

Balance sheet of Ajanta Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Ajanta Pharma is increasing.
Latest debt of Ajanta Pharma is -₹62.51 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹260.04 Crs.

Yes, profit is increasing.
The profit of Ajanta Pharma is ₹898 Crs for TTM, ₹816 Crs for Mar 2024 and ₹588 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Ajanta Pharma latest dividend payout ratio is 78.67% and 3yr average dividend payout ratio is 35.01%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech